Exploring metabolic alterations in PYCR2 deficiency: Unveiling pathways and clinical presentations of hypomyelinating leukodystrophy 10
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63645 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Berrak Bilginer Gürbüz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Hereditary Central Nervous System Demyelinating Diseases, Metabolomics, Proline, Pyrroline Carboxylate Reductases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Proline‐5‐carboxylate reductase 2, encoded by PYCR2 gene, is an enzyme that catalyzes the last step of proline synthesis from pyrroline‐5‐carboxylate synthetase to proline. PYCR2 gene defect causes hypomyelinating leukodystrophy 10. Up until now, to our knowledge around 38 patients with PYCR2 defect have been reported. Herein, we describe clinical, neuroradiological, biochemical findings, and metabolomic profiling of three new genetically related cases of PYCR2 defects from a large family. Cerebrospinal fluid (CSF) amino acid levels were measured and untargeted metabolomic profiling of plasma and CSF were conducted and evaluated together with the clinical findings in the patients. While plasma and CSF proline levels were found to be totally normal, untargeted metabolomic profiling revealed mild increases of glutamate, alpha‐ketoglutarate, and l ‐glutamate semialdehyde and marked increases of inosine and xanthine. Our findings and all the previous reports suggest that proline auxotrophy is not the central disease mechanism. Untargeted metabolomics point to mild changes in proline pathway and also in purine/pyrimidine pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Metabolism, Ankara Bilkent City Hospital, Ankara, Turkey.
- Division of Metabolism, Hacettepe University Institute of Child Health, Ankara, Turkey.
- Division of Genetics, Hacettepe University Institute of Child Health, Ankara, Turkey.
- Division of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Division of Radiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Bioinformatics, Hacettepe University Institute of Health, Ankara, Turkey.
ORCID-Profile: Berrak Bilginer Gürbüz, Basri Gülbakan, Rıza Köksal Özgül, Dilek Yalnızoğlu, Didem Yücel Yılmaz, Rahşan Göçmen, Can Koşukcu, Nurgün Kandemir, Neşe Vardar Acar, Bekir Salih, Ali Dursun
Zitieren
APA
Gürbüz, B. B., Gülbakan, B., Özgül, R. K., Yalnızoğlu, D., Yılmaz, D. Y., Göçmen, R., Koşukcu, C., Kandemir, N., Acar, N. V., Salih, B., & Dursun, A. (2024). Exploring metabolic alterations in PYCR2 deficiency: Unveiling pathways and clinical presentations of hypomyelinating leukodystrophy 10. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63645
Vancouver
Gürbüz BB, Gülbakan B, Özgül RK, Yalnızoğlu D, Yılmaz DY, Göçmen R, et al. Exploring metabolic alterations in PYCR2 deficiency: Unveiling pathways and clinical presentations of hypomyelinating leukodystrophy 10. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63645
BibTeX
@article{Grbz2024,
author = {Gürbüz, Berrak Bilginer and Gülbakan, Basri and Özgül, Rıza Köksal and Yalnızoğlu, Dilek and Yılmaz, Didem Yücel and Göçmen, Rahşan and Koşukcu, Can and Kandemir, Nurgün and Acar, Neşe Vardar and Salih, Bekir and Dursun, Ali},
title = {Exploring metabolic alterations in PYCR2 deficiency: Unveiling pathways and clinical presentations of hypomyelinating leukodystrophy 10},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63645}
}
EUVIMED